# Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia

> **NCT00407329** · — · COMPLETED · sponsor: **Queen's University** · enrollment: 30 (actual)

## Conditions studied

- BPH

## Interventions

- **PROCEDURE:** transurethral resection of the prostate

## Key facts

- **NCT ID:** NCT00407329
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-02
- **Final completion:** 2012-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407329, "Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00407329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*